Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures to transform the treatment of glaucoma, one of the world’s leading causes of blindness. We have pioneered
We launched the iStent, our first MIGS device, in the United States in 2012. We are leveraging our platform technology to build a comprehensive and proprietary portfolio of injectable